← ANALYST RATINGS · TIPRANKS
Stereotaxis (STXS): analyst forecast and price target
Analyst consensus
Moderate Buy2 Buy0 Hold0 Sell
Ratings of 2 analysts in the last 3 months · top analysts only12-month forecast
Based on 2 price targets given in the last 3 months, the average target is $3.00, the highest $3.00, the lowest $3.00. The average is +197.0% from the last price of $1.01.
Analyst ratings 5
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $1.50 → $1.00−33.3% | Hold | −1.0% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $1.50 → $1.00−33.3% | Hold | −1.0% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $1.50 → $1.00−33.3% | Hold | −1.0% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $1.50 → $1.00−33.3% | Hold | −1.0% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $1.50 → $1.00−33.3% | Hold | −1.0% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $1.50 → $1.00−33.3% | Hold | −1.0% | Reiterated | 03.10.26on TipRanks Oct 2 23:05 | — | |
| Daniel Stauder★★★★★★★★★★#1786 · hits 56% · avg +23.5% | Citizens JMP | $4.00 → $3.00−25.0% | Buy | +197.0% | Reiterated | 27.08.26on TipRanks 06:00 | +0.7%next day −1.1% · 5 days −5.7% | ↗ |
| AI Google Medical - Equipment and ServicesGemini 3.1Pro | TipRanks - Google | $1.50 | Hold | +48.5% | Reiterated | 18.08.26on TipRanks 00:05 | — | |
| AI xAi Medical - Equipment and ServicesxAI Grok-3 | TipRanks - xAI | $1.50 | Hold | +48.5% | Reiterated | 18.08.26on TipRanks 00:05 | — | |
| AI Anthropic Medical - Equipment and ServicesAnthropic Opus-4.6 | TipRanks - Anthropic | $1.50 | Hold | +48.5% | Reiterated | 18.08.26on TipRanks 00:05 | — | |
| AI DeepSeek Medical - Equipment and ServicesDeepSeek R1-0528 | TipRanks - DeepSeek | $1.50 | Hold | +48.5% | Reiterated | 18.08.26on TipRanks 00:05 | — | |
| AI OpenAI Medical - Equipment and ServicesOpenAI 4o | TipRanks - OpenAI | $1.50 | Hold | +48.5% | Reiterated | 18.08.26on TipRanks 00:05 | — | |
| AI PerPlexity Medical - Equipment and ServicesPerPlexity SonarPro | TipRanks - PerPlexity | $1.50 | Hold | +48.5% | Reiterated | 18.08.26on TipRanks 00:05 | — | |
| Frank Takkinen★★★★★★★★★★#11823 · hits 38% · avg −3.6% | Lake Street | $4.00 → $3.00−25.0% | Buy | +197.0% | Reiterated | 12.08.26on TipRanks 09:10 | −4.4%next day −2.1% · 5 days −1.0% | ↗ |
| Josh Jennings★★★★★★★★★★#3537 · hits 46% · avg +3.0% | TD Cowen | $5.00 → $3.00−40.0% | Buy | +197.0% | Reiterated | 12.08.26on TipRanks Aug 11 02:25 | +1.7%next day −4.4% · 5 days −6.4% | ↗ |
| Adam Maeder★★★★★★★★★★#1026 · hits 54% · avg +11.3% | Piper Sandler | $4.00 → $3.50−12.5% | Buy | +246.5% | Reiterated | 13.05.26on TipRanks 07:10 | −4.2%next day +4.1% · 5 days +0.1% | ↗ |
| Kyle Bauser★★★★★★★★★★#12304 · hits 37% · avg −14.9% | Roth MKM | $4.00 | Buy | +296.0% | Reiterated | 14.04.26on TipRanks 17:15 | −1.8%next day −0.2% · 5 days −5.1% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Stereotaxis
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $3.00 at a price of $1.23 (+143.9%); now: $3.00 at $1.01 (+197.0%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 3 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.05 (from $-0.06 to $-0.05). Last quarter: $-0.05.
Sales
Next quarter’s sales estimate — $10M (from $9M to $10M). Last quarter: $8M.
Best top-analyst consensus in the sector · Healthcare
About Stereotaxis
- CEO: David L. Fischel
- Employees: 131
- 710 North Tucker Boulevard, St. Louis, MO, 63101, US
- www.stereotaxis.com
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Data from the stock’s TipRanks forecast page, read 245 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗